Skip to main content
Have a personal or library account? Click to login
Implementing new clinical pharmacy services parallel to the introduction of centralized preparation of anti-cancer drugs Cover

Implementing new clinical pharmacy services parallel to the introduction of centralized preparation of anti-cancer drugs

Open Access
|Jan 2011

References

  1. Institute for safe medication practices: ISMP's list of high-alert medications. Pridobljeno 19.11.2009 s spletne strani: http://www.ismp.org/Tools/highalertmedications.pdf
  2. Phillips J, Beam S, Brinker A, et al: Retrospective analysis of mortalities associated with medication errors. Am J Health Syst Pharm 2001; 58: 1835-1841.10.1093/ajhp/58.19.183511596700
  3. Sonc M. Standardi kakovosti za področje onkološke farmacevtske dejavnosti. Ljubljana: Lekarniška zbornica Slovenije, 2009.
  4. Department of Health: The NHS cancer plan. London, HMSO, No. 22293, 2001.
  5. Green E, Johnston M, Trudeau M, Schwartz L, Poirer S, Macartney G, Milliken D. Safe handling of parenteral cytotoxics: recommenations for Ontario. J Oncol Pract posted online ahead of print on August 20, 2009.10.1200/JOP.091014279067020856737
  6. North East London Cancer Network NHS: Guidelines on the safe prescribing, handling and administration of cytotoxic drugs. London, Department of Health Publications, 2005.
  7. American Society of Health System Pharmacists: ASHP guidelines on handling hazardous drugs. Am J Health Syst Pharm 2006; 63: 1172-1193.10.2146/ajhp050529
  8. Mort D, Lansdown M, Smith N, et al: For better, for worse? London, National Confidential Enquiry into Patient Outcome and Death, 2008.
  9. Knez L, Laaksonen R, Duggan C, et al: Evaluation of clinical interventions made by pharmacists in cancer services. Pharm J 2008; 280: 277-280.
  10. Goldspiel BR, DeChristoforo R, Daniels CE: A continuous-improvement approach for reducing the number of chemotherapy-related medication errors. Am J Health Syst Pharm 2000; 57: S4-9.10.1093/ajhp/57.suppl_4.S411148943
  11. Macintyre J, Dalrymple H, MacLean F, et al: Development of a system for reporting pharmaceutical care issues in cancer patients receiving chemotherapy. Pharm J 2003; 271: 266-267.
  12. Liekweg A, Westfeld M, Jaehde U: From oncology pharmacy to pharmaceutical care: new contributions to multidisciplinary cancer care. Support Care Cancer 2004; 12: 3-79.10.1007/s00520-003-0539-414530957
  13. Slama C, Jerome J, Jacquot C, et al: Prescription errors with cytotoxic drugs and inadequacy of existing classifications. Pharm World Sci 2005; 27: 339-343.10.1007/s11096-005-6034-x16228634
  14. Markert A, Thierry V, Kleber M, et al: Chemotherapy safety and severe adverse events in cancer patients: strategies to efficiently avoid chemotherapy errors in in- and outpatient treatment. Int J Cancer 2009; 124: 722-728.10.1002/ijc.2399118989899
  15. Bolnišnica Golnik KOPA. Pridobljeno 19.11.2009 s spletne strani: www.klinika-golnik.si
  16. Baza podatkov o zdravilih Republike Slovenije. Pridobljeno 4.12.2009 s spletne strani: www.zdravila.net
  17. European Medicines Agency: Human Medicines. Pridobljeno 4.12.2009 s spletne strani: www.emea.europa.eu
  18. Cancer Care Ontario: Cancer Drugs. Pridobljeno 4.12.2009 s spletne strani: http://www.cancercare.on.ca
  19. National Comprehensive Cancer Network: NCCN Chemotherapy Order Templates. Pridobljeno 4.12.2009 s spletne strani: http://www.nccn.org
  20. Kuhlmann MK, Burkhardt G, Köhler H: Insights into potential cellular mechanisms of cisplatin nephrotoxicity and their clinical application. Nephrol Dial Transplant 1997; 12: 2478-2480.10.1093/ndt/12.12.24789430835
  21. Roila F, Hesketh PJ, Herrstedt J; Antiemetic Subcommitte of the Multinational Association of Supportive Care in Cancer: Prevention of chemotherapy- and radiotherapy-indiced emesis: results of the 2004 Perugia Internetional Antiemetic Consensus Conference. Ann Oncol 2006; 17: 20-28.10.1093/annonc/mdj07816314401
  22. Floyd J, Mirza I, Sachs B, et al: Hepatotoxicity of chemotherapy. Semin Oncol 2006; 33: 50-67.10.1053/j.seminoncol.2005.11.00216473644
  23. Allan EL, Barker KN: Fundamentals of medication error research. Am J Hosp Pharm 1990; 47: 555-571.10.1093/ajhp/47.3.555
  24. Pajk B: Neželeni učinki sistemskega zdravljenja raka. Onkologija za prakso, 2007; 2: 131-138.
  25. Jaehde U, Liekwig A, Simos S, et al: Minimising treatment-associated risks in systemic cancer therapy. Pharm World Sci 2008; 30: 161-168.10.1007/s11096-007-9157-4225365217906939
DOI: https://doi.org/10.2478/v10152-010-0024-7 | Journal eISSN: 1854-2476 | Journal ISSN: 0351-0026
Language: English, Slovenian
Page range: 12 - 23
Published online: Jan 17, 2011
Published in print: Jan 1, 2011
Published by: National Institute of Public Health, Slovenia
In partnership with: Paradigm Publishing Services

© 2011 Lea Knez, Maja Jošt, Janez Toni, Nadja Triller, Tanja Čufer, published by National Institute of Public Health, Slovenia
This work is licensed under the Creative Commons License.